CRBP
Corbus Pharmaceuticals Holdings, Inc.
Key Financials
Net Income
$-78537000
↓ 95.3%
Operating Income
$-85310000
↓ 75.1%
Revenue
$0
↓ 100.0%
Total Assets
$168.2M
↑ 7.9%
EPS (Diluted)
$-5.90
↓ 60.3%
Cash & Equivalents
$28.5M
↑ 65.7%
Shareholders' Equity
$147.5M
↑ 3.6%
Long-term Debt
$17.9M
↓ 17.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 9/30/2026 | View on SEC |
| 4 | 9/15/2026 | View on SEC |
| 8-K | 9/14/2026 | View on SEC |
| 4 | 8/17/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 4 | 8/12/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| 424B5 | 8/7/2026 | View on SEC |
| 144 | 8/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CRBP |
| Company Name | Corbus Pharmaceuticals Holdings, Inc. |
| CIK | 1595097 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-963-0103 |